Literature DB >> 28825299

Ferric Heme-Nitrosyl Complexes: Kinetically Robust or Unstable Intermediates?

Ashley B McQuarters1, Jeff W Kampf1, E Ercan Alp2, Michael Hu2, Jiyong Zhao2, Nicolai Lehnert1.   

Abstract

We have determined a convenient method for the bulk synthesis of high-purity ferric heme-nitrosyl complexes ({FeNO}6 in the Enemark-Feltham notation); this method is based on the chemical or electrochemical oxidation of corresponding {FeNO}7 precursors. We used this method to obtain the five- and six-coordinate complexes [Fe(TPP)(NO)]+ (TPP2- = tetraphenylporphyrin dianion) and [Fe(TPP)(NO)(MI)]+ (MI = 1-methylimidazole) and demonstrate that these complexes are stable in solution in the absence of excess NO gas. This is in stark contrast to the often-cited instability of such {FeNO}6 model complexes in the literature, which is likely due to the common presence of halide impurities (although other impurities could certainly also play a role). This is avoided in our approach for the synthesis of {FeNO}6 complexes via oxidation of pure {FeNO}7 precursors. On the basis of these results, {FeNO}6 complexes in proteins do not show an increased stability toward NO loss compared to model complexes. We also prepared the halide-coordinated complexes [Fe(TPP)(NO)(X)] (X = Cl-, Br-), which correspond to the elusive, key reactive intermediate in the so-called autoreduction reaction, which is frequently used to prepare {FeNO}7 complexes from ferric precursors. All of the complexes were characterized using X-ray crystallography, UV-vis, IR, and nuclear resonance vibrational spectroscopy (NRVS). On the basis of the vibrational data, further insight into the electronic structure of these {FeNO}6 complexes, in particular with respect to the role of the axial ligand trans to NO, is obtained.

Entities:  

Year:  2017        PMID: 28825299     DOI: 10.1021/acs.inorgchem.7b01493

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

1.  A Nonheme Sulfur-Ligated {FeNO}6 Complex and Comparison with Redox-Interconvertible {FeNO}7 and {FeNO}8 Analogues.

Authors:  Aniruddha Dey; Alex M Confer; Avery C Vilbert; Pierre Moënne-Loccoz; Kyle M Lancaster; David P Goldberg
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-17       Impact factor: 15.336

2.  Ferric nitrosylated myoglobin catalyzes peroxynitrite scavenging.

Authors:  Paolo Ascenzi; Giovanna De Simone; Grazia R Tundo; Carlos Platas-Iglesias; Massimiliano Coletta
Journal:  J Biol Inorg Chem       Date:  2020-03-14       Impact factor: 3.358

3.  A mononuclear nonheme {FeNO}6 complex: synthesis and structural and spectroscopic characterization.

Authors:  Seungwoo Hong; James J Yan; Deepika G Karmalkar; Kyle D Sutherlin; Jin Kim; Yong-Min Lee; Yire Goo; Pradip K Mascharak; Britt Hedman; Keith O Hodgson; Kenneth D Karlin; Edward I Solomon; Wonwoo Nam
Journal:  Chem Sci       Date:  2018-07-20       Impact factor: 9.825

4.  Insights into the Observed trans-Bond Length Variations upon NO Binding to Ferric and Ferrous Porphyrins with Neutral Axial Ligands.

Authors:  Rahul L Khade; Erwin G Abucayon; Douglas R Powell; George B Richter-Addo; Yong Zhang
Journal:  ACS Omega       Date:  2021-09-15

5.  Insights into the effect of distal histidine and water hydrogen bonding on NO ligation to ferrous and ferric heme: a DFT study.

Authors:  Fatemeh Fateminasab; Aurelien de la Lande; Reza Omidyan
Journal:  RSC Adv       Date:  2022-02-08       Impact factor: 3.361

Review 6.  Molecular understanding of heteronuclear active sites in heme-copper oxidases, nitric oxide reductases, and sulfite reductases through biomimetic modelling.

Authors:  Christopher J Reed; Quan N Lam; Evan N Mirts; Yi Lu
Journal:  Chem Soc Rev       Date:  2021-03-01       Impact factor: 54.564

7.  Nitric oxide and heme-NO stimulate superoxide production by NADPH oxidase 5.

Authors:  Elizabeth A Sweeny; Andrew P Hunt; Allison E Batka; Simon Schlanger; Nicolai Lehnert; Dennis J Stuehr
Journal:  Free Radic Biol Med       Date:  2021-06-15       Impact factor: 8.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.